Literature DB >> 29491103

Prognostic Significance of High EphA1-4 Expression Levels in Locally Advanced Gastric Cancer.

Mikito Inokuchi1, Masatoshi Nakagawa2, Nasri Baogok2, Yoko Takagi3, Toshiro Tanioka2, Kentaro Gokita2, Keisuke Okuno2, Kazuyuki Kojima4.   

Abstract

BACKGROUND/AIM: Erythropoietin-producing hepatocellular carcinoma receptor A (EphA) is associated with angiogenesis and invasive tumor progression. In this study, we evaluated the EphA1-4 expression levels in advanced gastric cancer. PATIENTS AND METHODS: Tumor tissues obtained from 114 patients with advanced gastric adenocarcinoma who underwent gastrectomy were analyzed. In addition, the impact of EPHA 1-4 mRNA expression on survival was analyzed using the Kaplan-Meier plotter database on the website.
RESULTS: High EphA 1, 2, and 4 expression levels were significantly related to recurrence (p<0.01, p=0.04, and p<0.01). Both high EphA 1 and 4 expression levels were independent predictors of relapse-free interval (hazard ratio [HR]=2.0, p=0.03; HR=2.4, p=0.03) and disease-specific survival (HR=2.0, 95% p=0.03; HR=2.5, p=0.02) on multivariate analysis. In the Kaplan-Meier plotter database, high EPHA2 mRNA expression was significantly associated with poor survival in patients with gastric cancer (p=0.0098), and high expression levels of EPHA1 and 4 tended to be associated with poor survival (p=0.050, p=0.052).
CONCLUSION: EphA 1, 2, and 4 may play key roles in recurrence and survival in patients with advanced gastric cancer. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Erythropoietin-producing hepatocellular carcinoma receptors; advanced gastric cancer

Mesh:

Substances:

Year:  2018        PMID: 29491103     DOI: 10.21873/anticanres.12402

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  The association between ephrin receptor-A1 expression and survival in patients with cancer: a meta-analysis.

Authors:  Hyun Min Koh; Bo Gun Jang; Dong Hui Lee; Chang Lim Hyun; Dong Chul Kim
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

2.  The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer.

Authors:  Wenfan Zhang; Huiling Cao; Jinhao Yang; Jing Zhao; Zheng Liang; Xiaodong Kang; Rong Wang
Journal:  BMC Cancer       Date:  2022-06-09       Impact factor: 4.638

Review 3.  Roles of EphA1/A2 and ephrin-A1 in cancer.

Authors:  Katsuaki Ieguchi; Yoshiro Maru
Journal:  Cancer Sci       Date:  2019-02-15       Impact factor: 6.716

4.  Helicobacter Pylori Targets the EPHA2 Receptor Tyrosine Kinase in Gastric Cells Modulating Key Cellular Functions.

Authors:  Marina Leite; Miguel S Marques; Joana Melo; Marta T Pinto; Bruno Cavadas; Miguel Aroso; Maria Gomez-Lazaro; Raquel Seruca; Ceu Figueiredo
Journal:  Cells       Date:  2020-02-24       Impact factor: 6.600

5.  Silencing of long non-coding RNA XIST represses gastric cancer progression through blocking NFκB pathway via inhibiting HNF4A-mediated transcription of EPHA1.

Authors:  Ping Li; Liuhua Wang; Pengfei Li; Fangyong Hu; Yi Cao; Dong Tang; Gang Ye; Hongbo Li; Daorong Wang
Journal:  Cancer Gene Ther       Date:  2020-11-16       Impact factor: 5.987

6.  The Expression Profile and Prognostic Values of EPHA Family Members in Breast Cancer.

Authors:  Xixun Zhang
Journal:  Front Oncol       Date:  2021-06-18       Impact factor: 6.244

7.  Association Between EphA1 and Tumor Microenvironment in Gastric Carcinoma and its Clinical Significance.

Authors:  Yong-Cang Wang; Yin Dai; Ge-Liang Xu; Wei Yu; Rui-Liang Quan; Ya-Jun Zhao
Journal:  Med Sci Monit       Date:  2020-03-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.